Advertisement
Advertisement

OSTX

OSTX logo

OS Therapies Incorporated

1.66
USD
Sponsored
-0.04
-2.35%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

1.70

+0.04
+2.41%

OS Therapies Incorporated Profile

About

OS Therapies Incorporated is a clinical stage oncology company focused on the identification, development and commercialization of treatments for Osteosarcoma and other solid tumors. The company's lead asset consists OST-HER2. OS Therapies Incorporated is based in NEW YORK.

Info & Links

CEO

Paul A.Romness

Headquarters

115 PULLMAN CROSSING ROAD, SUITE 103
GRASONVILLE, MD 20850, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.ostherapies.com

Auditor

MaloneBailey, LLP

Share holders

111

Employees

5

OS Therapies Incorporated Statistics

Valuation Measures

Market Capitalization2

71.47M

Enterprise Value

71.20M

Enterprise Value/EBITDA(ttm)

-2.61

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-6489.80%

Return on Invested Capital(ttm)

-1213.68%

Return on Assets(ttm)

-378.94%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-27.30M

Net Income Available to Common(ttm)

-28.75M

Diluted EPS(ttm)

-0.99

Share Statistics

Beta (5Y Monthly)

-2.98

52-Week Change

-15.74%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

39.53M

Dividend Yield

0.00%

Float4

35.46M

% Held by Insiders

10.30%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

269.80K

Total Cash Per Share(mrq)

0.01

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.56%

Quick Ratio(mrq)

0.03%

Book Value Per Share(mrq)

0.14

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.33

Free Cash Flow(ytd)

-10.51M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement